Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:21:48.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T20:27:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study page continues to show a 403 Forbidden error. The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T20:44:16.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with an error page and indicating that the study record at this URL is inaccessible.
    Difference
    20%
    Check dated 2026-09-19T22:07:33.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing Revision: v3.6.5, indicating a small update to the page's revision history. This change does not alter the displayed study details or other content.
    Difference
    0.1%
    Check dated 2026-08-29T21:00:27.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The page now displays a 503 Service Unavailable error with the message 'no healthy upstream', along with a Home link and a revision label, indicating the study page is currently inaccessible. This suggests a temporary site issue rather than a change to the study content.
    Difference
    19%
    Check dated 2026-08-08T17:55:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.